{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:56:58Z","timestamp":1783465018314,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71060-8","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T03:16:17Z","timestamp":1725246977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of office blood pressure with ischemic and bleeding events in patients undergoing percutaneous coronary intervention"],"prefix":"10.1038","volume":"14","author":[{"given":"Byung Sik","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Hun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woohyeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungdon","family":"Kook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hyo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"71060_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/ehjqcco\/qcaa076","volume":"8","author":"H Dai","year":"2020","unstructured":"Dai, H. et al. Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990\u20132017: Results from the Global Burden of Disease Study 2017. Eur. Heart J. Qual. Care Clin. Outcomes 8, 50\u201360 (2020).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"71060_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/ajh\/hpv131","volume":"29","author":"G Tocci","year":"2016","unstructured":"Tocci, G. et al. Blood pressure levels at the time of percutaneous coronary revascularization and risk of coronary in-stent restenosis. Am. J. Hypertens. 29, 509\u2013518 (2016).","journal-title":"Am. J. Hypertens."},{"key":"71060_CR3","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","volume":"79","author":"JS Lawton","year":"2022","unstructured":"Lawton, J. S. et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization. J. Am. Coll. Cardiol. 79, e21\u2013e129 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"71060_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"M Valgimigli","year":"2017","unstructured":"Valgimigli, M. et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 39, 213\u2013260 (2017).","journal-title":"Eur. Heart J."},{"key":"71060_CR5","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S0140-6736(19)31997-X","volume":"394","author":"D Thuijs","year":"2019","unstructured":"Thuijs, D. et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet 394, 1325\u20131334 (2019).","journal-title":"Lancet"},{"key":"71060_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.21326","volume":"3","author":"M Alkhouli","year":"2020","unstructured":"Alkhouli, M. et al. Trends in characteristics and outcomes of patients undergoing coronary revascularization in the United States, 2003\u20132016. JAMA Netw. Open 3, e1921326 (2020).","journal-title":"JAMA Netw. Open"},{"key":"71060_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 364, 937\u2013952 (2004).","journal-title":"Lancet"},{"key":"71060_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","volume":"75","author":"FD Fuchs","year":"2020","unstructured":"Fuchs, F. D. & Whelton, P. K. High blood pressure and cardiovascular disease. Hypertension 75, 285\u2013292 (2020).","journal-title":"Hypertension"},{"key":"71060_CR9","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams, B. et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur. Heart J. 39, 3021\u20133104 (2018).","journal-title":"Eur. Heart J."},{"key":"71060_CR10","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton, P. K. et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, Detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71, e13\u2013e115 (2018).","journal-title":"Hypertension"},{"key":"71060_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40885-023-00234-9","volume":"29","author":"HL Kim","year":"2023","unstructured":"Kim, H. L. et al. The 2022 focused update of the 2018 Korean hypertension society guidelines for the management of hypertension. Clin. Hypertens. 29, 11 (2023).","journal-title":"Clin. Hypertens."},{"key":"71060_CR12","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1038\/s41598-022-06627-4","volume":"12","author":"CW Lee","year":"2022","unstructured":"Lee, C. W. et al. Blood pressure and mortality after percutaneous coronary intervention: A population-based cohort study. Sci. Rep. 12, 2768 (2022).","journal-title":"Sci. Rep."},{"key":"71060_CR13","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/S0140-6736(16)31326-5","volume":"388","author":"E Vidal-Petiot","year":"2016","unstructured":"Vidal-Petiot, E. et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: An international cohort study. Lancet 388, 2142\u20132152 (2016).","journal-title":"Lancet"},{"key":"71060_CR14","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1161\/CIRCULATIONAHA.109.905687","volume":"122","author":"S Bangalore","year":"2010","unstructured":"Bangalore, S., Qin, J., Sloan, S., Murphy, S. A. & Cannon, C. P. What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. Circulation 122, 2142\u20132151 (2010).","journal-title":"Circulation"},{"key":"71060_CR15","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","volume":"137","author":"HM Garcia-Garcia","year":"2018","unstructured":"Garcia-Garcia, H. M. et al. Standardized end point definitions for coronary intervention trials: The academic research consortium-2 consensus document. Circulation 137, 2635\u20132650 (2018).","journal-title":"Circulation"},{"key":"71060_CR16","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran, R. et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. Circulation 123, 2736\u20132747 (2011).","journal-title":"Circulation"},{"key":"71060_CR17","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jacc.2014.05.044","volume":"64","author":"S Bangalore","year":"2014","unstructured":"Bangalore, S., Gong, Y., Cooper-DeHoff, R. M., Pepine, C. J. & Messerli, F. H. 2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study. J. Am. Coll. Cardiol. 64, 784\u2013793 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"71060_CR18","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","volume":"292","author":"SE Nissen","year":"2004","unstructured":"Nissen, S. E. et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: A randomized controlled trial. JAMA 292, 2217\u20132225 (2004).","journal-title":"JAMA"},{"key":"71060_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1161\/01.HYP.0000231662.77359.de","volume":"48","author":"FH Leenen","year":"2006","unstructured":"Leenen, F. H. et al. Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension 48, 374\u2013384 (2006).","journal-title":"Hypertension"},{"key":"71060_CR20","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"Wright, J. T. Jr. et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373, 2103\u20132116 (2015).","journal-title":"N. Engl. J. Med."},{"key":"71060_CR21","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad, D. et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet 387, 957\u2013967 (2016).","journal-title":"Lancet"},{"key":"71060_CR22","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","volume":"363","author":"S Julius","year":"2004","unstructured":"Julius, S. et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial. Lancet 363, 2022\u20132031 (2004).","journal-title":"Lancet"},{"key":"71060_CR23","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1097\/HJH.0000000000002127","volume":"37","author":"JL Kim","year":"2019","unstructured":"Kim, J. L. et al. Long-term clinical outcomes according to the mean observed blood pressure in patients with coronary artery disease after drug-eluting stent implantation. J. Hypertens. 37, 1898\u20131905 (2019).","journal-title":"J. Hypertens."},{"key":"71060_CR24","doi-asserted-by":"publisher","first-page":"884","DOI":"10.7326\/0003-4819-144-12-200606200-00005","volume":"144","author":"FH Messerli","year":"2006","unstructured":"Messerli, F. H. et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?. Ann. Intern. Med. 144, 884\u2013893 (2006).","journal-title":"Ann. Intern. Med."},{"key":"71060_CR25","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/S0140-6736(17)30754-7","volume":"389","author":"M B\u00f6hm","year":"2017","unstructured":"B\u00f6hm, M. et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: Results from ONTARGET and TRANSCEND trials. Lancet 389, 2226\u20132237 (2017).","journal-title":"Lancet"},{"key":"71060_CR26","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1093\/eurheartj\/ehq328","volume":"31","author":"S Bangalore","year":"2010","unstructured":"Bangalore, S. et al. J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. Eur. Heart J. 31, 2897\u20132908 (2010).","journal-title":"Eur. Heart J."},{"key":"71060_CR27","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.jacc.2016.07.754","volume":"68","author":"JW McEvoy","year":"2016","unstructured":"McEvoy, J. W. et al. Diastolic blood pressure, subclinical myocardial damage, and cardiac events: Implications for blood pressure control. J. Am. Coll. Cardiol. 68, 1713\u20131722 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"71060_CR28","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.amjcard.2010.03.056","volume":"106","author":"SJ Denardo","year":"2010","unstructured":"Denardo, S. J. et al. Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]). Am. J. Cardiol. 106, 498\u2013503 (2010).","journal-title":"Am. J. Cardiol."},{"key":"71060_CR29","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.111.060871","volume":"125","author":"G Ndrepepa","year":"2012","unstructured":"Ndrepepa, G. et al. Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention. Circulation 125, 1424\u20131431 (2012).","journal-title":"Circulation"},{"key":"71060_CR30","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","volume":"40","author":"P Urban","year":"2019","unstructured":"Urban, P. et al. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: A consensus document from the Academic Research Consortium for High Bleeding Risk. Eur. Heart J. 40, 2632\u20132653 (2019).","journal-title":"Eur. Heart J."},{"key":"71060_CR31","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41569-023-00901-2","volume":"20","author":"DA Gorog","year":"2023","unstructured":"Gorog, D. A. et al. De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: A Consensus Statement from an international expert panel on coronary thrombosis. Nat. Rev. Cardiol. 20, 830\u2013844 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"71060_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ahj.2019.10.001","volume":"220","author":"F D'Ascenzo","year":"2020","unstructured":"D\u2019Ascenzo, F. et al. Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries. Am. Heart J. 220, 108\u2013115 (2020).","journal-title":"Am. Heart J."},{"key":"71060_CR33","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","volume":"119","author":"S Subherwal","year":"2009","unstructured":"Subherwal, S. et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA Guidelines) Bleeding Score. Circulation 119, 1873\u20131882 (2009).","journal-title":"Circulation"},{"key":"71060_CR34","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1093\/eurheartj\/ehaa247","volume":"41","author":"M B\u00f6hm","year":"2020","unstructured":"B\u00f6hm, M. et al. Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: Data from the RE-LY trial. Eur. Heart J. 41, 2848\u20132859 (2020).","journal-title":"Eur. Heart J."},{"key":"71060_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.surg.2021.03.054","volume":"170","author":"AC Filiberto","year":"2021","unstructured":"Filiberto, A. C. et al. Intraoperative hypotension and complications after vascular surgery: A scoping review. Surgery 170, 311\u2013317 (2021).","journal-title":"Surgery"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71060-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71060-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71060-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T07:08:35Z","timestamp":1725520115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71060-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71060"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71060-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20310"}}